A model for the standardized measurement of synchrony in behavioral or biological states was proposed for use in comparative analyses of synchrony's adaptive significance. A recent critique attempts to discredit dimensionless (unitless) or standardized measures of synchrony in general and the propos
Problems with dimensionless measurement models of synchrony in biological systems
✍ Scribed by Jeffrey C. Schank
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 160 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0275-2565
No coin nor oath required. For personal study only.
✦ Synopsis
Synchrony is surprisingly complex even in the simplest cases. One strategy for simplifying complex phenomena is to define a dimensionless measurement model with the aim of (1) finding order, (2) comparing complex phenomena, and (3) making decisions about statistical significance. However, a model is only as good as its assumptions. In this paper, several types of dimensionless measurement models of synchrony among biological states are evaluated using the preceding criteria. These dimensionless measurement models are found to be inadequate even in the simplest cases of N individuals cycling through k non-overlapping states. Moreover, independent of their adequacy as measures of synchrony, there is the additional problem of the applicability of biological-state measurement models to rhythmic biological processes. Biological states are often just quantized observations of the phases of rhythmic biological processes. With the help of a concrete example, it is shown that quantizing the phases of a process into discrete states can lead to serious errors. These conclusions do not imply that the study of synchrony in biological systems is intractable. There are statistical approaches for detecting synchrony in groups and researchers are making progress towards understanding the general mechanisms of rhythmic phenomena in biological systems.
📜 SIMILAR VOLUMES
## Abstract ## Objective To evaluate health‐related quality of life (HRQOL) in patients with systemic sclerosis (SSc) using the Short Form 36 (SF‐36) and to correlate SF‐36 scores with clinical and biologic markers. ## Methods The SF‐36 was administered to 24 controls and 24 SSc patients. SSc pa